Insider · CIK 0001742485
Neil Kumar
ceoofficerdirector
Files at BBIO (BridgeBio Pharma, Inc.). First filing Nov 20, 2024, latest Sep 21, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 12
$0 bought, $48M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
BBIOOct 9, 2026 · close 65.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | BridgeBio Pharma, Inc. | $691k 10,000 shares | -2% | - | |
| 45Moderate | BridgeBio Pharma, Inc. | $4.2M 80,000 shares | -2% | +132% from low-1% from high | |
| 50Moderate | BridgeBio Pharma, Inc. | $1.3M 26,156 shares | -10% | +119% from low-5% from high | |
| 45Moderate | BridgeBio Pharma, Inc. | $3.7M 80,000 shares | -2% | +106% from low-7% from high | |
| 45Moderate | BridgeBio Pharma, Inc. | $3.4M 80,000 shares | -2% | +91% from low-5% from high | |
| 33Weak | BridgeBio Pharma, Inc. | $3.4M 101,156 shares | -42% | +51% from low-13% from high | |
| 45Moderate | BridgeBio Pharma, Inc. | $2.6M 75,000 shares | -2% | +53% from low-9% from high | |
| 38Weak | BridgeBio Pharma, Inc. | $2.8M 75,000 shares | -1% | +64% from low-2% from high | |
| 45Moderate | BridgeBio Pharma, Inc. | $2.5M 75,000 shares | -1% | - | |
| 35Weak | BridgeBio Pharma, Inc. | $1.1M 31,543 shares | -13% | - | |
| 50Moderate | BridgeBio Pharma, Inc. | $22M 600,000 shares | -11% | - | |
| 33Weak | BridgeBio Pharma, Inc. | $614k 27,389 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -8,721 | $69.01 | $602k | 496,965 | 21 d ago |
| Sep 17, 2026 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -1,279 | $69.57 | $89k | 495,686 | 21 d ago |
| Sep 4, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -14,525 | $51.15 | $743k | 4,703,922 | Sep 8, 2025 |
| Sep 4, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,475 | $51.85 | $284k | 4,698,447 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -2,300 | $51.95 | $119k | 4,696,147 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -16,800 | $53.16 | $893k | 4,679,347 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -900 | $53.80 | $48k | 4,678,447 | Sep 8, 2025 |
| Sep 4, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -14,558 | $51.16 | $745k | 901,128 | Sep 8, 2025 |
| Sep 4, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -5,442 | $51.85 | $282k | 895,686 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -2,300 | $51.96 | $120k | 893,386 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -16,900 | $53.16 | $898k | 876,486 | Sep 8, 2025 |
| Sep 5, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -800 | $53.80 | $43k | 875,686 | Sep 8, 2025 |
| Aug 20, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -25,728 | $48.81 | $1.3M | 223,518 | Aug 22, 2025 |
| Aug 20, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -428 | $49.25 | $21k | 223,090 | Aug 22, 2025 |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock | +64,697 | - | - | 282,101 | Aug 19, 2025 |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -32,855 | $51.32 | $1.7M | 249,246 | Aug 19, 2025 |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -33,544 | $0.00 | $0 | 201,264 | Aug 19, 2025 |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -19,599 | $0.00 | $0 | 195,993 | Aug 19, 2025 |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -11,554 | $0.00 | $0 | 161,753 | Aug 19, 2025 |
| Aug 7, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -6,784 | $45.09 | $306k | 4,751,663 | Aug 11, 2025 |
| Aug 7, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -13,216 | $45.64 | $603k | 4,738,447 | Aug 11, 2025 |
| Aug 8, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -11,795 | $45.88 | $541k | 4,726,652 | Aug 11, 2025 |
| Aug 8, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -8,205 | $46.71 | $383k | 4,718,447 | Aug 11, 2025 |
| Aug 7, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -6,784 | $45.09 | $306k | 948,902 | Aug 11, 2025 |
| Aug 7, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -13,216 | $45.64 | $603k | 935,686 | Aug 11, 2025 |
| Aug 8, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -11,795 | $45.88 | $541k | 923,891 | Aug 11, 2025 |
| Aug 8, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -8,205 | $46.71 | $383k | 915,686 | Aug 11, 2025 |
| Jul 1, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -18,300 | $42.50 | $778k | 4,780,147 | Jul 3, 2025 |
| Jul 1, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -1,700 | $42.88 | $73k | 4,778,447 | Jul 3, 2025 |
| Jul 2, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -20,000 | $42.73 | $855k | 4,758,447 | Jul 3, 2025 |
| Jul 1, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -18,400 | $42.51 | $782k | 977,286 | Jul 3, 2025 |
| Jul 1, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -1,600 | $42.89 | $69k | 975,686 | Jul 3, 2025 |
| Jul 2, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -20,000 | $42.73 | $855k | 955,686 | Jul 3, 2025 |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +64,696 | - | - | 276,414 | May 20, 2025 |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock10b5-1 | -32,854 | $33.84 | $1.1M | 243,560 | May 20, 2025 |
| May 19, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -25,756 | $33.32 | $858k | 217,804 | May 20, 2025 |
| May 19, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -400 | $33.75 | $13k | 217,404 | May 20, 2025 |
| May 20, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -75,000 | $33.40 | $2.5M | 4,798,447 | May 20, 2025 |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -33,544 | $0.00 | $0 | 234,808 | May 20, 2025 |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -19,599 | $0.00 | $0 | 215,592 | May 20, 2025 |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -11,553 | $0.00 | $0 | 173,307 | May 20, 2025 |
| Apr 22, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -75,000 | $34.11 | $2.6M | 4,873,447 | Apr 24, 2025 |
| Mar 25, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -75,000 | $36.87 | $2.8M | 4,948,447 | Mar 27, 2025 |
| Mar 19, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +71,208 | $0.00 | $0 | 71,208 | Mar 21, 2025 |
| Mar 19, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +184,860 | $0.00 | $0 | 184,860 | Mar 21, 2025 |
| Feb 25, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -37,899 | $33.36 | $1.3M | 5,060,548 | Feb 27, 2025 |
| Feb 25, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -37,101 | $33.79 | $1.3M | 5,023,447 | Feb 27, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +55,539 | - | - | 267,257 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock10b5-1 | -23,996 | $34.90 | $837k | 243,261 | Feb 19, 2025 |
| Feb 19, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -31,467 | $36.14 | $1.1M | 211,794 | Feb 19, 2025 |
| Feb 19, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -76 | $36.56 | $2,779 | 211,718 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,395 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -33,544 | $0.00 | $0 | 268,352 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -19,600 | $0.00 | $0 | 235,191 | Feb 19, 2025 |
| Jan 28, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -326,932 | $36.29 | $12M | 5,371,515 | Jan 30, 2025 |
| Jan 29, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -269,068 | $36.34 | $9.8M | 5,102,447 | Jan 30, 2025 |
| Jan 29, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.10b5-1 | -4,000 | $36.82 | $147k | 5,098,447 | Jan 30, 2025 |
| Dec 24, 2024 | BBIO BridgeBio Pharma, Inc. | GGift Common Stock | -4,685,725 | $0.00 | $0 | 211,718 | Dec 27, 2024 |
| Dec 24, 2024 | BBIO BridgeBio Pharma, Inc. | GGift Common Stockindirect: By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | +4,685,725 | $0.00 | $0 | 5,698,447 | Dec 27, 2024 |
| Dec 10, 2024 | BBIO BridgeBio Pharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +121,951 | $0.00 | $0 | 121,951 | Dec 12, 2024 |
| Nov 19, 2024 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -25,514 | $22.39 | $571k | 4,899,318 | Nov 20, 2024 |
| Nov 19, 2024 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -1,875 | $22.76 | $43k | 4,897,443 | Nov 20, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock | +55,537 | - | - | 4,952,980 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -28,148 | $23.72 | $668k | 4,924,832 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,394 | $0.00 | $0 | 2,395 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -33,544 | $0.00 | $0 | 301,896 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -19,599 | $0.00 | $0 | 254,791 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.